<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101235741</journal-id>
<journal-id journal-id-type="pubmed-jr-id">32200</journal-id>
<journal-id journal-id-type="nlm-ta">Am J Med Genet A</journal-id>
<journal-id journal-id-type="iso-abbrev">Am. J. Med. Genet. A</journal-id>
<journal-title-group>
<journal-title>American journal of medical genetics. Part A</journal-title>
</journal-title-group>
<issn pub-type="ppub">1552-4825</issn>
<issn pub-type="epub">1552-4833</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29193623</article-id>
<article-id pub-id-type="pmc">5942181</article-id>
<article-id pub-id-type="doi">10.1002/ajmg.a.38534</article-id>
<article-id pub-id-type="manuscript">NIHMS920423</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Cognitive and Behavioral Phenotype of Children with Pseudohypoparathyroidism Type 1A</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Perez</surname>
<given-names>Katia M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Evon B.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kahanda</surname>
<given-names>Sachini</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Duis</surname>
<given-names>Jessica</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Reyes</surname>
<given-names>Monica</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>JÃ¼ppner</surname>
<given-names>Harald</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shoemaker</surname>
<given-names>Ashley H.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Wake Forest School of Medicine</aff>
<aff id="A2">
<label>2</label>Department of Pediatrics, Vanderbilt University Medical Center</aff>
<aff id="A3">
<label>3</label>Division of Pediatric Endocrinology, Vanderbilt University Medical Center</aff>
<aff id="A4">
<label>4</label>Division of Medical Genetics and Genomic Medicine, Department of Pediatrics, Vanderbilt University Medical Center</aff>
<aff id="A5">
<label>5</label>Endocrine Unit and Pediatric Nephrology Unit, Massachusetts General Hospital and Harvard Medical School Boston, MA 02114</aff>
<author-notes>
<corresp id="FN1">Corresponding author: Ashley Shoemaker, MD, MSCI, 1500 21<sup>st</sup> Ave South St, Suite 1514, Nashville, TN, 37212 USA. Phone: 615-343-8116, <email>Ashley.H.Shoemaker@Vanderbit.Edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>6</day>
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>28</day>
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>2</month>
<year>2019</year>
</pub-date>
<volume>176</volume>
<issue>2</issue>
<fpage>283</fpage>
<lpage>289</lpage>
<!--elocation-id from pubmed: 10.1002/ajmg.a.38534-->
<abstract>
<sec id="S1">
<title>Context</title>
<p id="P1">Pseudohypoparathyroidism 1A (PHP1A) is a rare, genetic disorder. Most patients with PHP1A have cognitive impairment but this has not been systematically studied.</p>
</sec>
<sec id="S2">
<title>Objective</title>
<p id="P2">To evaluate cognition and behavior in children with PHP1A.</p>
</sec>
<sec id="S3">
<title>Design</title>
<p id="P3">We prospectively enrolled children with PHP1A, one unaffected sibling (when available) and controls matched on BMI/age/gender/race. Evaluations included cognitive and executive function testing. Parents completed questionnaires on behavior and executive function.</p>
</sec>
<sec id="S4">
<title>Main Outcome Measure</title>
<p id="P4">We hypothesized that children with PHP1A would have lower intelligent quotient (IQ) scores than controls.</p>
</sec>
<sec id="S5">
<title>Results</title>
<p id="P5">We enrolled 16 patients with PHP1A, 8 unaffected siblings and 15 controls. Results are presented as mean (SD). The PHP1A group had a composite IQ of 85.9 (17.2); 25% had a composite IQ &lt;-2SD. The PHP1A group had significantly lower IQs than matched controls (composite IQ -17.3, 95%CI -28.1 to -6.5, p&lt; 0.01) and unaffected siblings (composite IQ -21.5, 95%CI -33.9 to -9.1, p&lt; 0.01). Special education services were utilized for 93% of the patients with PHP1A. Deficits were observed in executive function and parents reported delayed adaptive behavior skills and increased rates of attention deficit hyperactivity disorder.</p>
</sec>
<sec id="S6">
<title>Conclusions</title>
<p id="P6">Children with PHP1A have lower intelligence quotient scores, poorer executive function, delayed adaptive behavior skills and increased behavior problems. The majority required special education services.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Pseudohypoparathyroidism</kwd>
<kwd>Albright Hereditary Osteodystrophy</kwd>
<kwd>cognition</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>